Related references
Note: Only part of the references are listed.The cardioprotective efficacy of TVP1022 in a rat model of ischaemia/reperfusion
Offir Ertracht et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Functional and molecular effects of imidazoline receptor activation in heart failure
Angelita Maria Stabile et al.
LIFE SCIENCES (2011)
Propargylamine Containing Compounds as Modulators of Proteolytic Cleavage of Amyloid-beta Protein Precursor: Involvement of MAPK and PKC Activation
Orit Bar-Am et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
TVP1022 Protects Neonatal Rat Ventricular Myocytes against Doxorubicin-Induced Functional Derangements
Alexandra Berdichevski et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Rasagiline: A novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity
Orly Weinreb et al.
PROGRESS IN NEUROBIOLOGY (2010)
Heart Disease and Stroke Statistics-2009 Update A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Donald Lloyd-Jones et al.
CIRCULATION (2009)
Why Do We Still Not Have Cardioprotective Drugs?
James M. Downey et al.
CIRCULATION JOURNAL (2009)
Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson's disease
Makoto Naoi et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
TVP1022 and propargylamine protect neonatal rat ventricular myocytes against doxorubicin-induced and serum starvation-induced cardiotoxicity
Yana Kleiner et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2008)
S1P-receptors in PC12 and transfected HEK293 cells:: Molecular targets of hypotensive imidazoline I1 receptor ligands
Gerhard J. Molderings et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives
S Mandel et al.
BRAIN RESEARCH REVIEWS (2005)
Rasagiline: Neurodegeneration, neuroprotection, and mitochondrial permeability transition
MBH Youdim et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
I1 imidazoline receptor-mediated effects on apoptotic processes in PC12 cells
L Dupuy et al.
CELL DEATH AND DIFFERENTIATION (2004)
The 11-imidazoline receptor in PC12 pheochromocytoma cells reverses NGF-induced ERK activation and induces MKP-2 phosphatase
L Edwards et al.
BRAIN RESEARCH (2003)
Noradrenaline release-inhibiting receptors on PC12 cells devoid of α2- and CB1 receptors:: similarities to presynaptic imidazoline and edg receptors
GJ Molderings et al.
NEUROCHEMISTRY INTERNATIONAL (2002)
The I1-imidazoline receptor in PC12 pheochromocytoma cells activates protein kinases C, extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK)
L Edwards et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Imidazoline I1 receptor-induced activation of phosphatidylcholine-specific phospholipase C elicits mitogen-activated protein kinase phosphorylation in PC12 cells
J Zhang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Effects of sphingosine 1-phosphate, a naturally occurring biologically active lysophospholipid, on the rat cardiovascular system
A Sugiyama et al.
JAPANESE JOURNAL OF PHARMACOLOGY (2000)
In vivo models of myocardial ischemia and reperfusion injury - Application to drug discovery and evaluation
SC Black
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2000)
Share Paper
